Medicure Inc. (TSXV:MPH)
Canada · Delayed Price · Currency is CAD 2.500
+0.600 (31.58%)
Aug 28, 2026, 3:56 PM EST
Medicure Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 32.08 | 28.86 | 21.91 | 21.69 | 23.07 | 21.74 | |
Revenue Growth | 38.25% | 31.72% | 0.98% | -5.94% | 6.08% | 87.29% |
Cost of Revenue | 19.89 | 17.11 | 8.82 | 7.71 | 6.99 | 9.03 |
Gross Profit | 12.19 | 11.75 | 13.09 | 13.99 | 16.08 | 12.71 |
Selling, General & Admin | 16.11 | 15.46 | 12.75 | 12.44 | 11.91 | 13.11 |
Research & Development | 3.33 | 3.18 | 3.08 | 2.41 | 2.75 | 1.8 |
Operating Expenses | 19.44 | 18.64 | 15.83 | 14.84 | 14.88 | 15.21 |
Operating Income | -7.25 | -6.89 | -2.74 | -0.85 | 1.19 | -2.5 |
Interest Expense | -0.12 | -0.09 | -0.04 | -0.05 | -0 | -0.07 |
Interest & Investment Income | 0.18 | 0.24 | 0.21 | 0.08 | 0.01 | 0.08 |
Currency Exchange Gain (Loss) | -0.07 | -0.12 | -0.07 | -0.11 | 0.05 | 0.03 |
Other Non Operating Income (Expenses) | -0.03 | -0.03 | - | 0.04 | -0.21 | -0.36 |
EBT Excluding Unusual Items | -7.28 | -6.89 | -2.64 | -0.9 | 1.04 | -2.81 |
Legal Settlements | - | - | 1.86 | - | - | - |
Other Unusual Items | - | - | - | - | 0.35 | 2.05 |
Pretax Income | -7.28 | -6.89 | -0.78 | -0.9 | 1.39 | -0.76 |
Income Tax Expense | 0.17 | 0.21 | 0.26 | 0.03 | 0.02 | -0.03 |
Earnings From Continuing Operations | -7.45 | -7.1 | -1.04 | -0.92 | 1.37 | -0.73 |
Net Income | -7.45 | -7.1 | -1.04 | -0.92 | 1.37 | -0.73 |
Net Income to Common | -7.45 | -7.1 | -1.04 | -0.92 | 1.37 | -0.73 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 |
Shares Change | - | - | - | - | 1.80% | -4.15% |
EPS (Basic) | -0.71 | -0.68 | -0.10 | -0.09 | 0.13 | -0.07 |
EPS (Diluted) | -0.72 | -0.68 | -0.10 | -0.09 | 0.13 | -0.07 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.93 | -0.56 | 1.38 | 2.08 | 1.81 | 3.61 |
Free Cash Flow Per Share | -0.18 | -0.05 | 0.13 | 0.20 | 0.17 | 0.35 |
Gross Margin | 38.00% | 40.71% | 59.75% | 64.48% | 69.69% | 58.46% |
Operating Margin | -22.61% | -23.87% | -12.49% | -3.94% | 5.17% | -11.47% |
Profit Margin | -23.23% | -24.59% | -4.74% | -4.25% | 5.92% | -3.34% |
Free Cash Flow Margin | -6.00% | -1.94% | 6.29% | 9.58% | 7.87% | 16.61% |
EBITDA | -5.62 | -5.06 | -1.01 | 1.32 | 3.25 | 0.65 |
EBITDA Margin | -17.51% | -17.54% | -4.63% | 6.07% | 14.08% | 2.99% |
D&A For EBITDA | 1.64 | 1.83 | 1.72 | 2.17 | 2.06 | 3.15 |
EBIT | -7.25 | -6.89 | -2.74 | -0.85 | 1.19 | -2.5 |
EBIT Margin | -22.61% | -23.87% | -12.49% | -3.94% | 5.17% | -11.47% |
Effective Tax Rate | - | - | - | - | 1.44% | - |